Fluoropolymers and the proposed universal PFAS REACH Restriction 28 March 2023 Fluoropolymers Product Group (FPG) The Fluoropolymers Product Group (FPG) represents Europe's leading fluoropolymer producers and experts.

Van: Verzonden: Aan: CC: Onderwerp: Bijlagen: (SPF Sant Publique - FOD Volksgezondheid) @sympatex.com> maandag, 5 juni 2023 11:58 Reach (SPF Sant Publique - FOD Volksgezondheid) Sympatex' study results on PFAS alternatives in textiles Thesis_PFAS_restriction_process_PPE_ _Feb2023.pdf Dear Madam or Sir, I am writing as CEO of Sympatex to share the study results regarding the restriction of PFAS compounds in textiles.

The universal PFAS restriction A civil society perspective Belgian REACH Committee Open session 6 September 2023 - Bond Beter Leefmilieu Who we are and who we represent Actions concerning PFAS - Broader EU civil society PFAS movement - Campaign Toxic-free future (EEB) - Stakeholder in Remediation Alliance Zwijndrecht - Advocacy for Flemish PFAS action plan and action plan Substances of Very High Concern Introduction `Forever pollution' mapping project (Le Monde): Over 17 000 contaminated sites across Europe More than 2 100 `hot spots' (PFAS concentration detected in levels that are hazardous) Belgium is one of them Why a PFAS restriction is justified now -1- 1.

From: Sent: To: Subject: SPF Sant Publique - FOD Volksgezondheid) jeudi, 7 dcembre 2023 15:33 ezondheid) FW: PFAS Restriction proposai -- Request for meeting with EPEE Bonjour, je voudrais intgrer le groupe CCPIE sur les PFAS, tout comme Clara Gruner et Evi Chielens.

1 OECD Global Forum on PFAS 12 - 13 February 2024 Auditorium, OECD Boulogne 46 Quai Alphonse Le Gallo, Boulogne-Billancourt, France Draft agenda Day 1 - Monday 12 February 2024 9.30-9.45 Welcoming remarks - Jo Tyndall, Director, Environment Directorate, OECD 9.45 - 11.00 Session I: Setting the scene PFAS Exposure, Testing, and Clinical Follow-Up Bruce N.

cartographier de manire fine les zones prsentant un risque plus important, et pouvoir travailler de faon mthodique face un polluant prsent largement dans notre quotidien.

ces substances extrmement proccupantes par les PFAS et d'autres substances proccupantes, entre autres.

#WIEDNER Angelika (ENV)#################################W#I#E#D#N#E#R# #A#n#g#e#l#i#k#a# #(#E#N#V#)##############################=######S##########

JEFFERSON MEDICAL COLLEGE of THO,MAS JEFFERSON UNIVERSITY DanielBaugh Institute Departmentof 4nafomy Officeof the Directorand Chairman December 7. 1983 Philadelphia1,9107 (215)928-7820 Mr.

SAFETY DATA SHEET PVDF SOLEF 1008/0001 Revision Date 19.05.2022 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1 Product identifier - Trade name PVDF SOLEF 1008/0001 1.2 Relevant identified uses of the substance or mixture and uses advised against Uses of the Substance/Mixture - For industrial use only 1.3 Details of the supplier of the safety data sheet Company SOLVAY FRANCE S.A. 9 rue des Cuirassiers, Immeuble Silex 2 Solvay, F- 69003 LYON Tel: + 33 (0)4 82 54 54 60 E-mail address solvay.com 1.4 Emergency telephone number 670 [CareChem 24] SECTION 2: Hazards identification 2.1 Classification of the substance or mixture Classification (Regulation (EC) No 1272/2008) - Not classified as hazardous product under the regulation above. 2.2 Label elements Regulation (EC) No 1272/2008 - Not labelled as hazardous product under the above regulation. 2.3 Other hazards which do not result in classification - If small particles are generated during further processing, handling or by other means, may form combustible concentrations in air. - Thermal decomposition can lead to release of toxic and corrosive gases.

Pimephales Summary.

Into the Future with Hydrogen-- Electrifying and Sustainable Green hydrogen is considered a source of hope in the decarbonization of industry and heavyduty vehicles.

3M MEEDICAL DEPARTMENT, CORPORATE TOXICOLOGY Protocol for Study No.

Description of PFAS use in application Position of PFAS in product - Example 20.35987.xxx Example 20.35987.xxx PTFE bead 9/19/2023 Confidential EGO information for internal use only, subject to NDA. 1

Pathology and Toxicology Riker Laboratories,Inc.